Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
Clinical trial NCT01479010 · TERMINATED
Trial details
- NCT number
- NCT01479010
- Sponsor
- Virginia Commonwealth University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.